Motley Fool Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

Motley Fool Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-131,935	Closed	-$4.51M	–	138
2017 Q4	$4.51M	Hold	131,935	–	–	0.98%	38
2017 Q3	$4.23M	Hold	131,935	–	–	0.85%	42
2017 Q2	$4.29M	Hold	131,935	–	–	0.89%	43
2017 Q1	$4.16M	Hold	131,935	–	–	0.9%	45
2016 Q4	$3.88M	Hold	131,935	–	–	0.86%	49
2016 Q3	$3.82M	Hold	131,935	–	–	0.84%	50
2016 Q2	$3.42M	Hold	131,935	–	–	0.75%	53
2016 Q1	$3.27M	Hold	131,935	–	–	0.68%	58
2015 Q4	$4.64M	Hold	131,935	–	–	0.93%	48
2015 Q3	$2.79M	Buy	131,935 +30,000	+29%	+$773K	0.55%	61
2015 Q2	$2.83M	Hold	101,935	–	–	0.5%	64
2015 Q1	$3.11M	Buy	101,935 +30,000	+42%	+$954K	0.55%	60
2014 Q4	$2.3M	Buy	71,935 +35,756	+99%	+$1.16M	0.43%	64
2014 Q3	$1.14M	Buy	+36,179	New	+$1.01M	0.24%	73

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Motley Fool Asset Management's GHDX Position: Q1 2018 in Review

Motley Fool Asset Management sold out of Genomic Health, Inc. (GHDX) in Q1 2018, closing a stake of 131,935 shares — an estimated $4.51M sold.

Motley Fool Asset Management first reported a position in GHDX in Q3 2014 and held it in 14 quarters. The position peaked at $4.64M in Q4 2015. 134 funds tracked by Wall St. Rank hold GHDX as of Q1 2018.

Motley Fool Asset Management reported no remaining Genomic Health, Inc. position as of Q1 2018 after selling out during the quarter.
Motley Fool Asset Management sold 131,935 Genomic Health, Inc. shares in Q1 2018, an estimated $4.51M.
Motley Fool Asset Management first reported a position in Genomic Health, Inc. in Q3 2014 and held it in 14 quarters.
Motley Fool Asset Management's Genomic Health, Inc. position peaked at $4.64M in Q4 2015.
134 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2018.

Based on Motley Fool Asset Management's 13F filing for Q1 2018, filed 4 May 2018.